GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (STU:4SG) » Definitions » Change In Payables And Accrued Expense

Sol-Gel Technologies (STU:4SG) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Sol-Gel Technologies Change In Payables And Accrued Expense?

Sol-Gel Technologies's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was €0.00 Mil. It means Sol-Gel Technologies's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Sol-Gel Technologies's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €0.75 Mil. It means Sol-Gel Technologies's Accounts Payable & Accrued Expense increased by €0.75 Mil from Dec. 2023 to Dec. 2024 .


Sol-Gel Technologies Change In Payables And Accrued Expense Historical Data

The historical data trend for Sol-Gel Technologies's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sol-Gel Technologies Change In Payables And Accrued Expense Chart

Sol-Gel Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.45 4.97 -7.84 1.34 0.75

Sol-Gel Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sol-Gel Technologies Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sol-Gel Technologies Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sol-Gel Technologies's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sol-Gel Technologies Business Description

Industry
Traded in Other Exchanges
Address
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Sol-Gel Technologies Headlines

No Headlines